Automation is Revolutionizing White Cell Differential Analysis; New Whitepaper Details How
BEDFORD, Mass., June 4, 2013 /PRNewswire/ -- Automation is revolutionizing white cell differential analysis, and it's delivering across-the-board benefits for hospital hematology laboratories, according to a newly published management brief. The brief is free and available to download at http://www.medicacorp.com/sysmex.
Performing manual white blood cell differentials can be a laborious and subjective process in hospital hematology laboratories. While the methodology has changed little over the years, the pressures of cost reductions, staff shortages, and rising patient expectations continue to build. The revolutionary solution - is automation.
Titled, "How Automation is Revolutionizing White Cell Differential Analysis," the new management brief reviews the concerns involved with manually performing white cell differentials - and outlines how new automated cell imaging analysis technology can deliver faster and more consistent results. The brief reports how automation has helped labs achieve improvements relating to cost, staffing, productivity, and quality-of-care related issues. Even small- to mid-volume hematology laboratories can benefit.
The brief discusses:
- Productivity and turn-around time
- Automating and simplifying process elements
- Advanced imaging and pattern recognition
- Matching automation capabilities to laboratory workflow
- Achieving true walkaway automation
- Standardization of differential analysis
- System maintenance
- Results recording and reporting
Download a copy of "How Automation is Revolutionizing White Cell Differential Analysis" at http://www.medicacorp.com/sysmex. Or, request a copy by calling Medica Corporation toll-free at 1-800-777-5983.
Medica Corporation is a leading provider of easy-to-use, easy-to-maintain, low-cost blood testing analyzers. Its affordable EasyCell® assistant for digital cell image analysis in hematology laboratories automates and simplifies the cell differential process by locating and preclassifying white blood cells. It typically reduces sample review times by 50% over the manual differentiation process which uses microscopes while helping the technologist achieve improved efficiency, accuracy, and precision.
Based in Bedford, Massachusetts, U.S.A., the company is focused on the global need to reduce the cost and improve the quality of health care. Medica's products include the EasyRA clinical chemistry analyzer, EasyLyte electrolyte analyzer, EasyBloodGas analyzer and the EasyCell assistant for hematology. For more information, visit http://www.medicacorp.com.
SOURCE Medica Corporation